10-May-2024
No headlines found.
Avantor to Participate in BofA Securities 2024 Health Care Conference
PRNewswire (Fri, 3-May 8:05 AM ET)
Avantor Reports First Quarter 2024 Results
PRNewswire (Fri, 26-Apr 6:00 AM ET)
Avantor to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024
PRNewswire (Mon, 1-Apr 8:00 AM ET)
Avantor Celebrates Supplier Award Honorees at 2024 European Sales Conference
PRNewswire (Mon, 26-Feb 8:05 AM ET)
Avantor to Participate in the 44th Annual TD Cowen Health Care Conference
PRNewswire (Tue, 20-Feb 8:05 AM ET)
Avantor Reports Fourth Quarter and Full Year 2023 Results
PRNewswire (Wed, 14-Feb 6:00 AM ET)
Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.
Avantor trades on the NYSE stock market under the symbol AVTR.
As of May 10, 2024, AVTR stock price climbed to $24.79 with 4,693,455 million shares trading.
AVTR has a beta of 1.07, meaning it tends to be more sensitive to market movements. AVTR has a correlation of 0.19 to the broad based SPY ETF.
AVTR has a market cap of $16.84 billion. This is considered a Large Cap stock.
Last quarter Avantor reported $2 billion in Revenue and $.22 earnings per share. This met revenue expectation and exceeded earnings estimates by $.02.
In the last 3 years, AVTR stock traded as high as $44.37 and as low as $16.63.
The top ETF exchange traded funds that AVTR belongs to (by Net Assets): VTI, VO, VXF, VTV, VOE.
AVTR stock has underperformed the market in the last year with a return of +20.5%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AVTR shares. However, AVTR has outperformed the market in the last 3 month and 2 week periods, returning +6.8% and +3.6%, while SPY returned +4.2% and +2.5%, respectively. This indicates AVTR has been having a stronger performance recently.
AVTR support price is $24.29 and resistance is $25.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVTR stock will trade within this expected range on the day.